These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

83 related items for PubMed ID: 19141841

  • 1. An automated Dengue virus microneutralization plaque assay performed in human Fc{gamma} receptor-expressing CV-1 cells.
    Rodrigo WW, Alcena DC, Rose RC, Jin X, Schlesinger JJ.
    Am J Trop Med Hyg; 2009 Jan; 80(1):61-5. PubMed ID: 19141841
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Comparative evaluation of three assays for measurement of dengue virus neutralizing antibodies.
    Putnak JR, de la Barrera R, Burgess T, Pardo J, Dessy F, Gheysen D, Lobet Y, Green S, Endy TP, Thomas SJ, Eckels KH, Innis BL, Sun W.
    Am J Trop Med Hyg; 2008 Jul; 79(1):115-22. PubMed ID: 18606774
    [Abstract] [Full Text] [Related]

  • 4. Differential enhancement of dengue virus immune complex infectivity mediated by signaling-competent and signaling-incompetent human Fcgamma RIA (CD64) or FcgammaRIIA (CD32).
    Rodrigo WW, Jin X, Blackley SD, Rose RC, Schlesinger JJ.
    J Virol; 2006 Oct; 80(20):10128-38. PubMed ID: 17005690
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Difference between the abilities of human Fcgamma receptor-expressing CV-1 cells to neutralize American and Asian genotypes of dengue virus 2.
    Rodrigo WW, Alcena DC, Kou Z, Kochel TJ, Porter KR, Comach G, Rose RC, Jin X, Schlesinger JJ.
    Clin Vaccine Immunol; 2009 Feb; 16(2):285-7. PubMed ID: 19038781
    [Abstract] [Full Text] [Related]

  • 10. Retrospective serological study on sequential dengue virus serotypes 1 to 4 epidemics in Tainan City, Taiwan, 1994 to 2000.
    Chang SF, Huang JH, Chen LK, Su CL, Liao TL, Chien LJ, Lin TH, Su CJ, Shu PY.
    J Microbiol Immunol Infect; 2008 Oct; 41(5):377-85. PubMed ID: 19122918
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Neutralization Assay for Chikungunya Virus Infection: Plaque Reduction Neutralization Test.
    Azami NA, Moi ML, Takasaki T.
    Methods Mol Biol; 2016 Oct; 1426():273-82. PubMed ID: 27233280
    [Abstract] [Full Text] [Related]

  • 13. Involvement of the Fc gamma receptor IIA cytoplasmic domain in antibody-dependent enhancement of dengue virus infection.
    Moi ML, Lim CK, Takasaki T, Kurane I.
    J Gen Virol; 2010 Jan; 91(Pt 1):103-11. PubMed ID: 19776239
    [Abstract] [Full Text] [Related]

  • 14. Development of a focus reduction neutralization test (FRNT) for detection of mumps virus neutralizing antibodies.
    Vaidya SR, Brown DW, Jin L, Samuel D, Andrews N, Brown KE.
    J Virol Methods; 2010 Jan; 163(1):153-6. PubMed ID: 19761798
    [Abstract] [Full Text] [Related]

  • 15. An improved plaque reduction virus neutralization assay for human metapneumovirus.
    de Graaf M, Herfst S, Schrauwen EJ, van den Hoogen BG, Osterhaus AD, Fouchier RA.
    J Virol Methods; 2007 Aug; 143(2):169-74. PubMed ID: 17420056
    [Abstract] [Full Text] [Related]

  • 16. Synthetic peptides containing B- and T-cell epitope of dengue virus-2 E domain III provoked B- and T-cell responses.
    Li S, Peng L, Zhao W, Zhong H, Zhang F, Yan Z, Cao H.
    Vaccine; 2011 May 09; 29(20):3695-702. PubMed ID: 21419774
    [Abstract] [Full Text] [Related]

  • 17. A simple assay system for infection-enhancing and -neutralizing antibodies to dengue type 2 virus using layers of semi-adherent K562 cells.
    Konishi E, Tabuchi Y, Yamanaka A.
    J Virol Methods; 2010 Feb 09; 163(2):360-7. PubMed ID: 19883692
    [Abstract] [Full Text] [Related]

  • 18. An immunocytometric assay based on dengue infection via DC-SIGN permits rapid measurement of anti-dengue neutralizing antibodies.
    Martin NC, Pardo J, Simmons M, Tjaden JA, Widjaja S, Marovich MA, Sun W, Porter KR, Burgess TH.
    J Virol Methods; 2006 Jun 09; 134(1-2):74-85. PubMed ID: 16417930
    [Abstract] [Full Text] [Related]

  • 19. Dengue virus neutralization in cells expressing Fc gamma receptors.
    Chawla T, Chan KR, Zhang SL, Tan HC, Lim AP, Hanson BJ, Ooi EE.
    PLoS One; 2013 Jun 09; 8(5):e65231. PubMed ID: 23717696
    [Abstract] [Full Text] [Related]

  • 20. Development and evaluation of serotype- and group-specific fluorogenic reverse transcriptase PCR (TaqMan) assays for dengue virus.
    Callahan JD, Wu SJ, Dion-Schultz A, Mangold BE, Peruski LF, Watts DM, Porter KR, Murphy GR, Suharyono W, King CC, Hayes CG, Temenak JJ.
    J Clin Microbiol; 2001 Nov 09; 39(11):4119-24. PubMed ID: 11682539
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.